Perbedaan Sumber Sinergi Makmur Tbk. dan UBC Medical Indonesia Tbk.: Sumber Sinergi Makmur Tbk. diperdagangkan di Rp53 (kapitalisasi pasar 280,39 M, volume 24 jam 8,19 jt), sedangkan UBC Medical Indonesia Tbk. diperdagangkan di Rp148 (kapitalisasi pasar 576,7 M, volume 24 jam 3,48 jt). Perbedaan utamanya: UBC Medical Indonesia Tbk. jauh lebih besar — sekitar 2,1× kapitalisasi pasar Sumber Sinergi Makmur Tbk., dan Sumber Sinergi Makmur Tbk. lebih aktif diperdagangkan (8,19 jt vs 3,48 jt). Mana yang lebih baik tergantung tujuan investasimu.
| IOTF | LABS | |
|---|---|---|
Kapitalisasi Pasar | 280,39 M | 576,7 M |
Volume | 8,19 jt | 3,48 jt |
Lot | 81,95 rb | 34,82 rb |
Perputaran | 427,34 jt | 522,79 jt |
Harga Rata-rata | 52,15 | 150,13 |
Nilai Transaksi | 427,34 jt | 522,79 jt |
Harga Ekuilibrium Indikatif | 53 | 148 |
Volume Ekuilibrium Indikatif | 1,14 rb | 350 |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Sumber Sinergi Makmur Tbk (the Company) was established based on Deed Number 88 dated May 19, 2015 of H. Zainuddin, S.H., a notary domiciled in Jakarta. The company started its commercial activities in 2015. The controlling party of the Company and the party who is the ultimate beneficial owner of the Company is Alamsyah.
Selengkapnya di halaman IOTF →PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.
Selengkapnya di halaman LABS →